Atlas Trials

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

Clinical trial NCT03445858 · COMPLETED

Trial details

NCT number
NCT03445858
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Childhood Solid TumorChildhood LymphomaRelapsed CancerRefractory CancerAdult Solid TumorAdult Lymphoma
Start date
2018-02-12
Primary completion
2023-11-07
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.